Trigger
Contact us

Join our advanced solid tumor clinical trial

Have you been diagnosed with PIK3CA Mutant Clear Cell Ovarian, Endometrial, or Colorectal Cancer? You may be eligible to participate in our clinical study of Serabelisib in Combination with an Insulin Suppressing Diet.

Contact us today to find out if you are eligible to join our clinical trial.

SER-ISD1-001: A Phase 1b Study of Serabelisib in Combination with an Insulin Suppressing Diet With or Without Nab-paclitaxel in Subjects With Advanced Solid Tumors With PIK3CA Mutations

Locations

  • University of Alabama, Birmingham AL

  • Hoag Memorial Hospital, Newport Beach CA

  • Pacific Cancer Center, Anaheim CA 

  • Valkyrie Clinical Trials, Los Angeles CA
  • Community Health Network, Indianapolis IN
  • Memorial Sloan Kettering, New York NY
  • University of Pennsylvania, Philadelphia PA

  • Avera, Sioux Falls SD

  • Lumi Research, Kingwood TX
  • Medical College of Wisconsin, Milwaukee WI

Find out if you are eligible

Learn more at clinicaltrials.gov

Questions? Contact us, we're here to help!

We are committed to your fight, and to creating better cancer treatments for you and many others like you in the future.


Contact us